C07C 59/06
Glycolic acid
C07C59/06 (Glycolic acid) appears on 43 US grants and 47 published applications in this corpus.
Search patents in C07C- Granted patents
- 43
- Published applications
- 47
- Assignees
- 50
- Inventors
- 156
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 0 | 3 |
| 2017 | 3 | 6 |
| 2018 | 3 | 3 |
| 2019 | 3 | 3 |
| 2020 | 4 | 3 |
| 2021 | 2 | 4 |
| 2022 | 1 | 1 |
| 2023 | 2 | 6 |
| 2024 | 1 | 7 |
| 2025 | 3 | 2 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof26 May 2026US 12,637,470 B2Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
- Salts of (2R, 6R)-hydroxynorketamine, their crystal forms, and methods of making the same17 Feb 2026US 12,552,737 B2The United States Government as represented by the Department of Veterans Affairs
- Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same11 Nov 2025US 12,466,835 B1Kura Oncology, Inc.
- Pharmaceutically acceptable acid salt of free base of GLP1 receptor agonist, and preparation method therefor23 Sep 2025US 12,421,245 B2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same7 May 2026US 2026/0125390 A1
- Salts and solid forms of (s)- or racemic 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and methods of using the same9 Apr 2026US 2026/0098035 A1Celgene Corporation
- Pharmaceutically acceptable acid salt of free base of glp1 receptor agonist, and preparation method therefor9 Apr 2026US 2026/0098042 A1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Hyperbranched polyglycerol-coated particles and methods of making and using thereof13 Nov 2025US 2025/0345248 A1Yale University
- Method for selecting additive for suppressing nitrosation reaction, and formulation for suppressing generation of nitroso compounds14 Aug 2025US 2025/0255965 A1Sawai Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Process for producing peracids from aliphatic hydroxy carboxylic acids69US 4,617,090 AThe United States of America as represented by the United States Department of Energy · 1986
- Salt forms of a xanthine compound44US 8,865,729 B2Boehringer Ingelheim International GmbH · 2014
- Organo-platinum complex38US 4,359,425 AShionogi & Co., Ltd. · 1982
- Rapidly degradable poly (hydroxyacid) compositions35US 5,278,256 AE. I. Du Pont de Nemours and Company · 1994
- Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine34US 9,212,183 B2Boehringer Ingelheim International GmbH · 2015